Evidence map›Paper›PMID 39141219›Full record

ArticleNeotropical entomology2024

Neem-Extract Formulation on Hypothenemus hampei Preference and Performance in Arabica Coffee Fruits and Artificial Diet.

José Justo Escobar Padilla, Bruno Henrique Sardinha de Souza, Filipe de Souza Carneiro, Evandro Keller

Abstract read
PubMed Publisher
In one paragraph

Article in Neotropical entomology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

José Justo Escobar PadillaFederal Univ of Lavras, Lavras, MG, Brazil.
Bruno Henrique Sardinha de SouzaFederal Univ of Lavras, Lavras, MG, Brazil. brunosouza@ufla.br.ORCID http://orcid.org/0000-0002-2802-2688
Filipe de Souza CarneiroFederal Univ of Lavras, Lavras, MG, Brazil.
Evandro KellerOpeneem Bioscience, São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coffee berry borer (CBB) Hypothenemus hampei is a major biotic threat to coffee production worldwide. Studies have reported negative effects on CBB by oil-based formulations of neem (Azadirachta indica), but little information is available for other neem-extract formulations. This study evaluated CBB preference and performance in arabica coffee fruits and artificial diet treated with a neem-extract formulation (Openeem Plus®) in the field and laboratory conditions. Field experiments were performed using CBB females artificially infested in cherry or green coffee fruits confined in voile-fabric cages tied to branches of neem-treated and control plants, recording the adult mortality and offspring production. Dual-choice and no-choice bioassays assessed CBB preference and development in fruits and artificial diet treated with the neem extract compared to controls in the laboratory, respectively. As main results obtained in the field and laboratory experiments, the neem extract significantly reduced CBB oviposition in both cherry and green fruits, as well as in artificial diet compared to controls. However, the botanical product did not affect CBB adult survival and preference in the laboratory bioassays. The neem extract is promising for use in pest management strategies in sustainable arabica coffee crops by reducing CBB oviposition and offspring. These effects can contribute to lowering the pest population buildup along the crop cycle and damage potential to coffee production.

Indexed as

AzadirachtaCoffeaFruitOvipositionWeevilsAnimalsDietFemaleInsect ControlArtificial dietAzadirachta indicaCoffee berry borerIPMOviposition

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.